Catalyst OrthoScience received FDA 510(k) clearance to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head. This is reportedly the market’s first stemmed arthroplasty system featuring an ellipsoid humeral head, which is designed to allow for more accurate restoration of the natural joint kinematics compared to spherical head designs.
Catalyst expects to begin limited U.S. release in 2Q23, followed by a larger commercial launch later in 2023.
In addition to its fully convertible stemmed total shoulder arthroplasty system, Catalyst offers:
The CSR Total Shoulder
The R1 Reverse Shoulder
3D Targeting Preoperative Shoulder Replacement Planning Software
“Catalyst now offers a comprehensive range of TSA solutions, including an anatomic stemless implant, a modernized reverse and an anatomic stemmed implant that can be converted to a reverse,” said Dr. Steven Goldberg, Chief Medical Officer of Catalyst. “Our fully convertible system is the first to feature an ellipsoid anatomic head in a stemmed option, and it shares the design philosophy of the Catalyst CSRTM Anatomic Stemless System which has been shown in multiple peer-reviewed clinical studies to provide excellent clinical outcomes. The stem design of the system features an inlay design with an anatomic neck shaft angle combined with a focus on a streamlined technique for efficiencies in the operating room.”
Catalyst OrthoScience received FDA 510(k) clearance to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head. This is reportedly the market’s first stemmed arthroplasty system featuring an ellipsoid humeral head, which is designed to allow for more accurate restoration of the natural joint...
Catalyst OrthoScience received FDA 510(k) clearance to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head. This is reportedly the market’s first stemmed arthroplasty system featuring an ellipsoid humeral head, which is designed to allow for more accurate restoration of the natural joint kinematics compared to spherical head designs.
Catalyst expects to begin limited U.S. release in 2Q23, followed by a larger commercial launch later in 2023.
In addition to its fully convertible stemmed total shoulder arthroplasty system, Catalyst offers:
The CSR Total Shoulder
The R1 Reverse Shoulder
3D Targeting Preoperative Shoulder Replacement Planning Software
“Catalyst now offers a comprehensive range of TSA solutions, including an anatomic stemless implant, a modernized reverse and an anatomic stemmed implant that can be converted to a reverse,” said Dr. Steven Goldberg, Chief Medical Officer of Catalyst. “Our fully convertible system is the first to feature an ellipsoid anatomic head in a stemmed option, and it shares the design philosophy of the Catalyst CSRTM Anatomic Stemless System which has been shown in multiple peer-reviewed clinical studies to provide excellent clinical outcomes. The stem design of the system features an inlay design with an anatomic neck shaft angle combined with a focus on a streamlined technique for efficiencies in the operating room.”
Copy to clipboard 
